Prohibition or Coffee Shops: Regulation of Amphetamine and Methylphenidate for Enhancement Use by Healthy Adults
Prohibition or Coffee Shops: Regulation of Amphetamine and Methylphenidate for Enhancement Use by Healthy Adults
复制标题
DOI：
10.1080/15265161.2013.794875
复制
发表时间：
2013-07-01
影响因子：
13.4
通讯作者：
Dubljevic, Veljko
中科院分区：
文献类型：
--
作者：
Dubljevic, Veljko
本文分析了适当的公共政策，以加强使用两个最重要的兴奋剂药物：利他林（哌甲酯）和Adderall（混合安非他明盐）。作者认为，对认知增强药物的适当监管不能是对认知增强进行一般性讨论的结果，而必须根据具体情况进行。从最近提出的认知增强药物的税收方法开始，作者分析了现有的适度宽松的监管模式。经过对哌醋甲酯和苯丙胺的相关特性的全面分析，作者得出结论，对健康成年人的增强使用适度宽松的许可法规可能适用于哌醋甲酯的缓释形式。然而，由于其危险性，安非他明和速释形式的哌醋甲酯不应轻易提供给健康的成年人，需要加以禁止。
This article analyzes appropriate public policies for enhancement use of two most important stimulant drugs: Ritalin (methylphenidate) and Adderall (mixed amphetamine salts). The author argues that appropriate regulation of cognition enhancement drugs cannot be a result of a general discussion on cognitive enhancements as such, but has to be made on a case-by-case basis. Starting from the recently proposed taxation approach to cognition enhancement drugs, the author analyzes available, moderately permissive models of regulation. After a thorough analysis of relevant characteristics of methylphenidate and amphetamine, the author concludes that a moderately liberal permissive regulation of enhancement use by healthy adults might be appropriate for extended release forms of methylphenidate. However, due to their danger profile, amphetamine and instant release forms of methylphenidate should not be made readily available to healthy adults and would need to be prohibited.